거대세포바이러스 망막염의 임상 양상 및 치료에 대한 고찰

참고문헌 (21)

1. Report of KCDC:2005 epidemiologic data of HIV, "AIDS in Korea"
2. Choi BS, "Immunologic characteristics of newly diagnosed HIV infeced patients in Korea.", Korean J Infect Dis, (32), pp.115~122 (2000)
3. Drew WL, "Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group.", N Engl J Med, (333), pp.615~620 (1995)
4. Whitley RJ, "Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy:recommendations of an international panel. International AIDS Society-USA.", Arch Intern Med, (158), pp.957~969 (1998)
5. Craig JM, "Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease.", Proc Soc Exp Biol Med, (94), pp.4~12 (1957)
6. Clyde S, "Cytomegalovirus. In:Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed.", pp.1780~ (2005), Philadelphia, Elsevier Churchill Livingstone
7. Masur H, "Advances in the management of AIDS-related cytomegalovirus retinitis", Ann Intern Med, (125), pp.126~136 (1996)
8. Kim HB, "Cytomegalovirus infection in AIDS patients", Korean J Infect Dis, (30), pp.358~364 (1998)
9. "Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group", Ophthalmology, (101), pp.1250~1261 (1994)
10. Lin DY, "Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients:natural history and clinical predictors.", Retina, (22), pp.268~277 (2002)
11. Lopez-Cortes LF, "Influence of the response to induction therapy on the rate of progression of cytomegalovirus retinitis in AIDS patients on intravitreal maintenance therapy.", Eur J Clin Microbiol Infect Dis, (20), pp.385~388 (2001)
12. Henderly DE, "Cytomegalovirus retinitis and response to therapy with ganciclovir", Ophthalmology, (94), pp.425~434 (1987)
13. Zurlo JJ, "Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection.", Ann Intern Med, (118), pp.12~17 (1993)
14. Spector SA, "Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS", J Virol, (73), pp.7027~7030 (1999)
15. Jabs DA, "Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy.", Ophthalmology, (112), pp.771~779 (2005)
16. Ho M, "Cytomegalovirus. In:Biology and Infection. 2nd edn.", pp.440~ (1991), New York:Prenum
17. Erice A, "Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.", JAMA, (257), pp.3062~3067 (1987)
18. Anderson RD, "Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg", d dosing regimens in human immunodeficiency virus- and cytomegalovirus- seropositive patients., 1995, pp.(17), 425~432
19. Freeman RB, "Valganciclovir:oral prevention and treatment of cytomegalovirus in the immunocompromised host.", Expert Opin Pharmacother, (5), pp.2007~2016 (2004)
20. Jouan M, "RESTIMOP Study Team:Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.", AIDA, (15), pp.23~31 (2001)
21. Piketty C, "Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis.", Clin Microbiol Infect, (6), pp.117~120 (2000)

관련 논문AI추천